Yiran Gan 4/3/25 Yiran Gan 4/3/25 Magnetic Susceptibility Reduction Method for Magnetically Labeled Immunoassay Read More Yiran Gan 4/3/25 Yiran Gan 4/3/25 Nano-particles for High-sensitivity Immunomagnetic Detection of Human C-reactive Protein Read More Yiran Gan 4/3/25 Yiran Gan 4/3/25 Magnetic nano-particles and their applications in immunoassay Read More Yiran Gan 4/3/25 Yiran Gan 4/3/25 Nanomagnetic particles for SQUID-based magnetically labeled immunoassay Read More Yiran Gan 4/3/25 Yiran Gan 4/3/25 Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible Read More Yiran Gan 4/3/25 Yiran Gan 4/3/25 Development of antibody functionalized magnetic nanoparticles for the immunoassay of carcinoembryonic antigen: a feasibility study for clinical use Read More Magqu 4/3/25 Magqu 4/3/25 Parkinsonism in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Clinical Features and Biomarkers Read More Magqu 5/28/19 Magqu 5/28/19 Cerebral white matter damage in patients with end-stage kidney disease associates with cognitive impairment Read More Newer Posts
Yiran Gan 4/3/25 Yiran Gan 4/3/25 Magnetic Susceptibility Reduction Method for Magnetically Labeled Immunoassay Read More
Yiran Gan 4/3/25 Yiran Gan 4/3/25 Nano-particles for High-sensitivity Immunomagnetic Detection of Human C-reactive Protein Read More
Yiran Gan 4/3/25 Yiran Gan 4/3/25 Magnetic nano-particles and their applications in immunoassay Read More
Yiran Gan 4/3/25 Yiran Gan 4/3/25 Nanomagnetic particles for SQUID-based magnetically labeled immunoassay Read More
Yiran Gan 4/3/25 Yiran Gan 4/3/25 Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible Read More
Yiran Gan 4/3/25 Yiran Gan 4/3/25 Development of antibody functionalized magnetic nanoparticles for the immunoassay of carcinoembryonic antigen: a feasibility study for clinical use Read More
Magqu 4/3/25 Magqu 4/3/25 Parkinsonism in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Clinical Features and Biomarkers Read More
Magqu 5/28/19 Magqu 5/28/19 Cerebral white matter damage in patients with end-stage kidney disease associates with cognitive impairment Read More
